Massimiliano Bonifacio, Gianni Binotto, Elena Maino, Elisabetta Calistri, Luciana Marin, Luigi Scaffidi, Luca Frison, Federico De Marchi, Mauro Krampera, Giampiero Semenzato, Renato Fanin, Achille Ambrosetti, and Mario Tiribelli. 2015. “Imatinib-Treated Chronic Myeloid Leukemia Patients With Discordant Response Between Cytogenetic and Molecular Tests at 3 and 6 Month Time-Points Have a Reduced Probability of Subsequent Optimal Response”. Haematologica 100 (8). Pavia, Italy, e299-e301. https://doi.org/10.3324/haematol.2015.124685.